Steward Partners Investment Advisory’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Sell
706
-19
-3% -$5.6K ﹤0.01% 2226
2026
Q1
$215K Hold
725
﹤0.01% 1977
2025
Q4
$220K Buy
725
+3
+0.4% +$982 ﹤0.01% 1884
2025
Q3
$246K Buy
722
+23
+3% +$6.98K ﹤0.01% 1761
2025
Q2
$169K Sell
699
-8
-1% -$1.96K ﹤0.01% 1835
2025
Q1
$192K Hold
707
﹤0.01% 1668
2024
Q4
$131K Buy
707
+8
+1% +$1.64K ﹤0.01% 1842
2024
Q3
$157K Sell
699
-5
-0.7% -$900 ﹤0.01% 1649
2024
Q2
$100K Buy
704
+12
+2% +$1.85K ﹤0.01% 1774
2024
Q1
$108K Sell
692
-2
-0.3% -$322 ﹤0.01% 1727
2023
Q4
$125K Buy
694
+294
+74% +$53.2K ﹤0.01% 1583
2023
Q3
$71.9K Hold
400
﹤0.01% 1738
2023
Q2
$71.3K Hold
400
﹤0.01% 1737
2023
Q1
$86.2K Hold
400
﹤0.01% 1644
2022
Q4
$88K Hold
400
﹤0.01% 1600
2022
Q3
$54K Hold
400
﹤0.01% 1749
2022
Q2
$65K Buy
+400
New +$62.5K ﹤0.01% 1679
2021
Q2
Sell
-400
Closed -$139K 7450
2021
Q1
$139K Buy
+400
New +$132K ﹤0.01% 1453
2020
Q3
Sell
-2
Closed 2872
2020
Q2
$0 Buy
+2
New +$326 ﹤0.01% 2764
2018
Q3
Sell
-54
Closed -$8K 2731
2018
Q2
$8K Buy
+54
New +$9.63K ﹤0.01% 1839

Other funds holding ONC

Steward Partners Investment Advisory's ONC Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its BeOne Medicines Ltd (ONC) stake by 2.6% in Q2 2026, selling an estimated $5.6K and leaving 706 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

Steward Partners Investment Advisory first reported a position in ONC in Q2 2018 and has held it in 20 quarters since. The position peaked at $246K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Steward Partners Investment Advisory held 706 shares of BeOne Medicines Ltd worth $201K as of Q2 2026.
  • Steward Partners Investment Advisory sold 19 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.6K.
  • BeOne Medicines Ltd made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2226 holding.
  • Steward Partners Investment Advisory first reported a position in BeOne Medicines Ltd in Q2 2018 and has held it in 20 quarters since.
  • Steward Partners Investment Advisory's BeOne Medicines Ltd position peaked at $246K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.